Reporting of Human Adenoviruses Has Declined Since COVID-19
Six HAdV types accounted for 88.3 percent of typed specimens reported during 2017 to 2023
COVID-19 Infection Not Linked to Changes in MS Symptom Severity
Immediate effect of COVID-19 infection on the SymptoMScreen total score was minimal
Prevalence of Post-COVID-19 Condition in Adults 8.4 Percent in 2023
In 2023, 3.6 percent currently had post-COVID-19 condition and 2.3 percent had activity-limiting PCC
Brief Outpatient Rehab Program Beneficial for Post-COVID-19 Condition
Statistically and clinically significant improvement seen in Short-Form 36 Physical Function Subscale scores
Therapeutic-Dose Anticoagulation Linked to Lower Mortality in COVID-19
Administration of therapeutic- versus prophylactic-dose anticoagulation with heparins linked to lower mortality in patients hospitalized for COVID-19
2000 to 2024 Saw Rise in Physician Union Petitions
Most organizing efforts motivated by nonfinancial factors
Just Over Half of Children Hospitalized With Flu Receive Antivirals
Factors associated with higher odds of antiviral receipt include clinical influenza testing, ICU admission
Tecovirimat No Aid for Time to Lesion Resolution With Mpox
Additionally, interim analysis shows that the antiviral is safe but has no effect on pain among adults with mild-to-moderate clade II mpox